Madrona Invests in Charta’s $55M Series B to Apply AI to Pre-billing Medical Chart Review
Madrona is increasing its investment in Charta, a company that uses AI to review complete medical charts before billing to reduce costly denials and appeals; language models enable checking charts against coding rules and payer policies at scale. The firm argues a shared pre-billing accuracy standard could cut waste in claims adjudication that previously arose from sparse, post-hoc reviews.